Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-25 @ 7:14 PM
Study NCT ID:
NCT07088432
Status:
COMPLETED
Last Update Posted:
2025-07-28
First Post:
2025-07-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Intravenous Dexamethasone for Prolonging Sensory Block in Spinal Anesthesia
Sponsor:
Tunis University
Organization:
Study Overview
Official Title:
Intravenous Dexamethasone for Prolonging the Sensory Block Duration of Spinal Anesthesia: A Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2025-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to learn if intravenous dexamethasone can help prolong the effect of spinal anesthesia in adults having elective pelvic, urologic, or proctologic surgery. The study also looks at whether dexamethasone improves pain control after surgery and whether it causes any side effects.
The main questions it aims to answer are:
Does intravenous dexamethasone increase how long the spinal anesthesia lasts?
Does it reduce the need for pain medications after surgery?
Does it cause more or fewer side effects compared to a placebo?
In this study:
Participants were randomly assigned to receive either 8 mg of intravenous dexamethasone or a placebo (salt water).
All participants received standard spinal anesthesia with bupivacaine and sufentanil.
Researchers measured how long the spinal anesthesia lasted and when the first pain medication was needed after surgery.
Participants were monitored for side effects such as low blood pressure, nausea, vomiting, and slow heart rate.
Surgeon satisfaction with anesthesia quality was also recorded.
Participants did not receive any additional procedures beyond routine care. The study found that dexamethasone helped prolong the spinal anesthesia and delayed the need for pain relief, without increasing side effects.
The main questions it aims to answer are:
Does intravenous dexamethasone increase how long the spinal anesthesia lasts?
Does it reduce the need for pain medications after surgery?
Does it cause more or fewer side effects compared to a placebo?
In this study:
Participants were randomly assigned to receive either 8 mg of intravenous dexamethasone or a placebo (salt water).
All participants received standard spinal anesthesia with bupivacaine and sufentanil.
Researchers measured how long the spinal anesthesia lasted and when the first pain medication was needed after surgery.
Participants were monitored for side effects such as low blood pressure, nausea, vomiting, and slow heart rate.
Surgeon satisfaction with anesthesia quality was also recorded.
Participants did not receive any additional procedures beyond routine care. The study found that dexamethasone helped prolong the spinal anesthesia and delayed the need for pain relief, without increasing side effects.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: